Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FFAR1 | O14842 | 8/20 | 0.61 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.61 |
| ▸ | LMNA | P02545 | 1/20 | 0.61 |
| ▸ | FFAR4 | Q5NUL3 | 2/20 | 0.53 |
| ▸ | MMP2 | P08253 | 1/20 | 0.51 |
| ▸ | S1PR1 | P21453 | 4/20 | 0.51 |
| ▸ | S1PR3 | Q99500 | 2/20 | 0.51 |
| ▸ | S1PR4 | O95977 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8478544 | 0.86 | FFAR1 (0.71) | FFAR1L3MBTL1LMNAFFAR4 | |
| SCHEMBL928209 | 0.86 | L3MBTL1 (0.62) | FFAR1L3MBTL1LMNAFFAR4MMP2 | |
| Hydrochloric Acid SCHEMBL25249937 | 0.85 | FFAR1 (0.55) | FFAR1L3MBTL1LMNAS1PR1S1PR3 | |
| SCHEMBL20799670 | 0.83 | FFAR1 (0.65) | FFAR1L3MBTL1LMNAFFAR4S1PR1 | |
| SCHEMBL11949155 | 0.83 | L3MBTL1 (0.76) | FFAR1L3MBTL1LMNAFFAR4MMP2 | |
| Hydrochloric Acid SCHEMBL25249708 | 0.82 | FFAR1 (0.55) | FFAR1L3MBTL1LMNAS1PR1S1PR3 | |
| SCHEMBL4432054 | 0.82 | ALOX15 (0.57) | FFAR1 | |
| SCHEMBL12117110 | 0.82 | L3MBTL1 (0.67) | FFAR1L3MBTL1LMNAMMP2 | |
| SCHEMBL2198008 | 0.82 | L3MBTL1 (0.67) | FFAR1L3MBTL1LMNAMMP2 | |
| SCHEMBL1809723 | 0.81 | L3MBTL1 (0.69) | FFAR1L3MBTL1LMNAFFAR4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-102746214-A | Novel indoline compounds | FOURNIER LAB SA | 2012-10-24 | — | — | CN | disclosed |
| US-7465811-B2 | Indoline compounds | LABORATOIRES FOURNIER S.A. (FR) | 2008-12-16 | — | — | US | disclosed |
| US-20080119465-A1 | Novel Indoline Compounds | LABORATORIES FOURNIER S.A. (FR) | 2008-05-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080119465-A1 | Novel Indoline Compounds | GPR119, INSR, IRS1 | FFAR1 55/4885L3MBTL1 1493/4885LMNA 1943/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.